Action Goldenwell Biotech (PK) - GWLL

Goldenwell Biotech Inc (PK) (GWLL) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

0,52

( - )

Prix Achat

0,52

Prix Vente

0,52

Volume échangé

0,00 Fourchette du Jour 0,00

0,20 Plage de 52 semaines 10,00

Cap du marché

51,48M

Clôture Veille

0,52

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

US$ 1 566

Actions en circulation

99 000 000

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-686,02

Bénéfice par action (BPA)

-0

Chiffre d'affairess (LTM)

62,34k

Bénéfice net (LTM)

-75,12k

Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Ma... Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement. The company was incorporated in 2019 and is based in Hudson, Ohio. Show more

Secteur

Consumer Staples

Industrie

Consumer Products - Foods

Siège social

Hudson, United States

Fondé

2026

Goldenwell Biotech Inc (PK) est coté dans le secteur Consumer Staples de la OTC Markets avec le ticker GWLL. Le dernier cours de clôture d'Goldenwell Biotech (PK) était de US$0,52. Au cours de la dernière année, les actions de Goldenwell Biotech (PK) ont été négociées dans une fourchette de prix de US$ 0,20 à US$ 10,00.

Goldenwell Biotech (PK) compte actuellement 99 000 000 actions en circulation. La capitalisation boursière d'Goldenwell Biotech (PK) est de US$51,48 million. Goldenwell Biotech (PK) a un ratio cours/bénéfice (ratio PE) de -686.02.

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0.52	0.52	0.52	710	0.52	CS
4	-0.0278	-5.07484483388	0.5478	0.995	0.51	1430	0.6702763	CS
12	-0.49	-48.5148514851	1.01	1.01	0.51	1231	0.82953535	CS
26	-2.48	-82.6666666667	3	3	0.51	823	1.12163568	CS
52	0.32	160	0.2	10	0.2	882	2.42050253	CS
156	0.27	108	0.25	10	0.0586	1411	1.23284468	CS
260	0.225	76.2711864407	0.295	10	0.0586	1668	1.0302257	CS

GWLL - Frequently Asked Questions (FAQ)

What is the current Goldenwell Biotech Inc (PK) share price?

The current share price of Goldenwell Biotech Inc (PK) is US$ 0,52

How many Goldenwell Biotech Inc (PK) shares are in issue?

Goldenwell Biotech Inc (PK) has 99 000 000 shares in issue

What is the market cap of Goldenwell Biotech Inc (PK)?

The market capitalisation of Goldenwell Biotech Inc (PK) is USD 51,48M

What is the 1 year trading range for Goldenwell Biotech Inc (PK) share price?

Goldenwell Biotech Inc (PK) has traded in the range of US$ 0,20 to US$ 10,00 during the past year

What is the PE ratio of Goldenwell Biotech Inc (PK)?

The price to earnings ratio of Goldenwell Biotech Inc (PK) is -686,02

What is the cash to sales ratio of Goldenwell Biotech Inc (PK)?

The cash to sales ratio of Goldenwell Biotech Inc (PK) is 825,77

What is the registered address of Goldenwell Biotech Inc (PK)?

The registered address for Goldenwell Biotech Inc (PK) is 581 Boston Mills Road, Hudson, Ohio, 44236

Which industry sector does Goldenwell Biotech Inc (PK) operate in?

Goldenwell Biotech Inc (PK) operates in the Consumer Products - Foods sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Goldenwell Biotech Inc (PK) (GWLL)

Goldenwell Biotech Inc (PK) (GWLL) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Goldenwell Biotech Inc (PK)

GWLL Dernières nouvelles

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

GWLL - Frequently Asked Questions (FAQ)

GWLL Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Goldenwell Biotech Inc (PK) (GWLL)

Goldenwell Biotech Inc (PK) (GWLL) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Goldenwell Biotech Inc (PK)

GWLL Dernières nouvelles

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

GWLL - Frequently Asked Questions (FAQ)

GWLL Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités